Skip to content
OpenCapital
Get started

Repligen RGEN Free cash flow margin

Free cash flow margin at other companies

TEC
Bio-TechneTECH
22.3%+4.0pp
Revvity logo
RevvityRVTY
17%-1.9pp
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
15.7%-2.1pp
Danaher logo
DanaherDHR
21.4%+0.8pp
Agilent Technologies logo
Agilent TechnologiesA
15%-2.9pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
13.8%-0.2pp

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$7.45B-7.1%
Enterprise value$7.55B+2.1%
P/E144.9×—
P/S10.1×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Calculated from Repligen’s reported figures.

free cash flow/total revenue=21.2%

Based on trailing twelve months.

The official record: Repligen’s 10-Q, filed November 18, 2024, on SEC EDGAR. View the filing →

Ask your AI about Repligen's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's free cash flow margin?
Repligen (RGEN) reported free cash flow margin of 21.2% in Q3 2024.
How has Repligen's free cash flow margin changed year-over-year?
Repligen's free cash flow margin increased by 40.5% year-over-year, from 15.1% to 21.2%.
What is the long-term trend for Repligen's free cash flow margin?
Over 3 years (2020 to 2023), Repligen's free cash flow margin has grown at a 2.9% compound annual growth rate (CAGR), from 11% to 12%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.